ERNEST DE PAOLANTONIO, CPA
Chief Finance Officer
Ernie De Paolantonio has more than 40 years of pharmaceutical industry experience. Most recently, he was Chief Financial Officer of Journey Medical Corporation where he was part of the team that took the company public. Mr. De Paolantonio held several leadership positions, including Chief Financial Officer, of BioDelivery Sciences International, Inc., a public specialty company, Chief Financial Officer of CorePharma LLC, a privately held specialty generic company.
Ernie began his career spending 17 years at GlaxoSmithKline, including group controller responsible for $3.5 billion in sales. De Paolantonio, a licensed CPA, received his B.A. from Lycoming College and his MBA in Finance from Saint Joseph’s University.
Mission
An innovative drug is one thing. An innovative delivery system that lets millions more benefit from it is another.
Heritage
A legacy of delivering firsts.
Technologies
Pioneering penetrating breakthroughs.
Manufacturing
Cutting-edge technologies demand cutting-edge production.
Partnerships
Game-changing delivery platforms lead to game-changing products.